Scribe Therapeutics raised $128.7M in its upsized IPO and surged 67% on its Nasdaq debut, signaling renewed biotech investor appetite for CRISPR
The post Scribe Therapeutics surges 67% after $129M IPO as biotech market heats up appeared first on Crypto Briefing.